Self-reported flaring varies during the menstrual cycle in systemic lupus erythematosus compared with rheumatoid arthritis and fibromyalgia

Rheumatology

Volumn 50, Issue 4, 2011, Pages 703-708

  Colangelo, Kim ^a   Haig, Sara ^b   Bonner, Ashley ^c   Zelenietz, Caleb ^a   Pope, Janet ^a,b  

^a WESTERN UNIVERSITY   (Canada)

^b MCMASTER UNIVERSITY   (Canada)

^c MCMASTER UNIVERSITY   (Canada)

Author keywords

Fatigue; Fibromyalgia; Flare; Hormones; Menstrual cycle; Pain; Rheumatoid arthritis; Systemic lupus erythematosus

Indexed keywords

ESTROGEN; ORAL CONTRACEPTIVE AGENT; PROGESTERONE;

ADULT; ARTICLE; DISEASE ACTIVITY; DISEASE EXACERBATION; FATIGUE; FEMALE; FIBROMYALGIA; HEALTH SURVEY; HORMONE RELEASE; HUMAN; MAJOR CLINICAL STUDY; MENSTRUAL CYCLE; PAIN; PRIORITY JOURNAL; QUESTIONNAIRE; RHEUMATOID ARTHRITIS; SCORING SYSTEM; SELF REPORT; SYSTEMIC LUPUS ERYTHEMATOSUS; VISUAL ANALOG SCALE;

ADULT; ARTHRITIS, RHEUMATOID; CASE-CONTROL STUDIES; CONTRACEPTIVES, ORAL; FATIGUE; FEMALE; FIBROMYALGIA; HUMANS; LUPUS ERYTHEMATOSUS, SYSTEMIC; MENSTRUAL CYCLE; MIDDLE AGED; PAIN MEASUREMENT; QUALITY OF LIFE; SELF REPORT; SEVERITY OF ILLNESS INDEX;

EID: 79952794714     PISSN: 14620324     EISSN: 14620332     Source Type: Journal    
DOI: 10.1093/rheumatology/keq360     Document Type: Article

References (25)

1. Danchenko N, Satia J, Anthony M. Epidemiology of systemic lupus erythematosus: a comparison of worldwide disease burden. Lupus 2006;15:308-18.
2. Lu L, Wallace D, Ishimori M, Scofield R, Weisman M. Male systemic lupus erythematosus: a review of sex disparities in this disease. Lupus 2010;19:119-29.
3. Rothfield N. Clinical features of systemic lupus erythematosus. In: Kelley WN, Harris ED, Ruddy S, Sledge CB, eds. Textbook of rheumatology. Philadelphia: WB Saunders, 1981.
4. Grimaldi C, Jeganathan V, Diamond B. Hormonal regulation of B cell development: 17 beta-estradiol impairs negative selection of high-affinity DNA-reactive B cells at more than one developmental checkpoint. J Immunol 2006;176:2703-10.
5. Rider V, Jones S, Evans M, Abdou N. Molecular mechanisms involved in the estrogen-dependent regulation of calcineurin in systemic lupus erythematosus T cells. Clin Immunol 2000;95:124-34.
6. Aronica S, Dozier A, Fanti P, Nazareth M. Altered bone marrow cell sensitivity in the lupus-prone NZB-W mouse: regulation of CFU-GM colony formation by estrogen, tamoxifen and thrombopoietin. Lupus 2000;9: 271-7.
7. Shabanova S, Ananieva L, Alekberova Z. Ovarian function and disease activity in patients with systemic lupus erythematosus. Clin Exp Rheumatol 2008;26:436-41.
8. Doria A, Cutollo M, Ghirardello A. Steroid hormones and disease activity during pregnancy in systemic lupus erythematosus. Arthritis Rheum 2002;47:202-9.
9. Alamanos Y, Voulgari P, Drosos A. Incidence and prevalence of rheumatoid arthritis, based on the 1987 American College of Rheumatology criteria: a systematic review. Semin Arthritis Rheum 2006;36:182-8.
10. Kaipiainen-Seppanen O, Aho K, Nikkarinen M. Regional differences in the incidence of rheumatoid arthritis in Finland in 1995. Ann Rheum Dis 2001;60:128-32.
11. De Man Y, Hazes J, van de Geijn F, Krommenhoeck C, Dolhain R. Measuring disease activity and functionality during pregnancy in patients with rheumatoid arthritis. Arthritis Rheum 2007;57:716-22.
12. Zen M, Ghirardello A, Iaccarino L et al. Hormones, immune response and pregnancy in healthy women and SLE patients. Swiss Med Wkly 2010;140:187-201.
13. Cutolo M, Villaggio B, Seriolo B et al. Synovial fluid estrogens in rheumatoid arthritis. Autoimmune Rev 2004; 3:193-8.
14. Petri M, Robinson C. Oral contraceptives and systemic lupus erythematosus. Arthritis Rheum 1997;40:797-803.
15. Cutolo M, Brizzolara R, Atzeni F, Capellino S, Straub RH, Puttini PC. The immunomodulatory effects of estrogens: clinical relevance in immune-mediated rheumatic diseases. Ann N Y Acad Sci 2010;1193:36-42.
16. Bernier M, Mikaeloff Y, Hudson M, Suissa S. Combined oral contraceptive use and the risk of systemic lupus erythematosus. Arthritis Rheum 2009;61:476-81.
17. Petri M, Kim MY, Kalunian KC et al. Combined oral contraceptives in women with systemic lupus erythematosus. N Engl J Med 2005;353:2550-8.
18. Forslind K, Hafstrom I, Ahlmen M, Svensson B; the BARFOT study group. Sex: a major predictor of remission in early rheumatoid arthritis? Ann Rheum Dis 2007;66: 46-52.
19. McNally J, Matheson D, Bakowsky V. The epidemiology of self-reported fibromyalgia in Canada. Chronic Dis Can 2006;27:9-16.
20. Okifuji A, Turk D. Sex hormones and pain in regularly menstruating women with fibromyalgia syndrome. J Pain 2006;7:851-9.
21. Samborski W, Sobieska M, Pieta P, Drews K, Brzosko M. Normal profile of sex hormones in women with primary fibromyalgia. Ann Acad Med Stetin 2005;51:23-6.
22. Kajantie E, Phillips D. The effects of sex and hormonal status on the physiological response to acute psychosocial stress. Psychoneuroendocrinology 2006;31:151-78.
23. Ostensen M, Rugelsjoen A, Wigers S. The effect of reproductive events and alterations of sex hormone levels on the symptoms of fibromyalgia. Scand J Rheumatol 1997;26:355-60.
24. Colangelo K, Pope J, Peschken C. The minimally important difference for patient reported outcomes in systemic lupus erythematosus including the HAQ-DI, pain, fatigue, and SF-36. J Rheumatol 2009;36:2231-7.
25. Smedslund G, Mowinckel P, Heiberg T, Kvien TK, Hagen KB. Does the weather really matter? A cohort study of influences of weather and solar conditions on daily variations of joint pain in patients with rheumatoid arthritis. Arthritis Rheum 2009;61:1243-7.